MYCN
Showing 1 - 25 of 48
Tumor Tissue Samples From Newly Diagnosed Neuroblastoma or
Recruiting
- Ganglioneuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +258 more
Mar 23, 2022
Neuroblastoma, Ganglioneuroblastoma, Ganglioneuroma Trial (No Intervention NA)
Not yet recruiting
- Neuroblastoma
- +2 more
- No Intervention NA
- (no location specified)
Dec 31, 2021
Neuroblastoma Trial in France (Blood sampling)
Active, not recruiting
- Neuroblastoma
- Blood sampling
-
Amiens, France
- +26 more
May 18, 2021
Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)
Recruiting
- Solid Tumor, Childhood
- +2 more
-
Boston, Massachusetts
- +5 more
Dec 27, 2022
High-Risk Neuroblastoma Trial in Worldwide (Vincristine, Carboplatin, Etoposide)
Recruiting
- High-Risk Neuroblastoma
- Vincristine
- +13 more
-
Villejuif, Val De Marne, France
- +15 more
Sep 17, 2021
Neuroblastoma, Medulloblastoma, Typical Teratoid Rhabdoid Tumor Trial in Charlotte (eflornithine HCl)
No longer available
- Neuroblastoma
- +5 more
- eflornithine HCl
-
Charlotte, North CarolinaLevine Children's Hospital
Apr 20, 2022
High-Risk Neuroblastoma Trial in Krakow (Chemoimmunotherapy (Dinutuximab beta in combination with chemo))
Recruiting
- High-Risk Neuroblastoma
- Chemoimmunotherapy (Dinutuximab beta in combination with chemotherapy)
-
Krakow, Malopolska, PolandUniversity Children Hospital
Mar 8, 2022
Patients With Previously Diagnosed High-Risk Neuroblastoma
Active, not recruiting
- Recurrent Neuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Birmingham, Alabama
- +97 more
Oct 28, 2022
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (drug,
Active, not recruiting
- Disseminated Neuroblastoma
- +4 more
- cyclophosphamide
- +14 more
-
Birmingham, Alabama
- +120 more
Mar 3, 2022
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Advanced Solid Tumors Trial in Tianjin (Drug: SYHA1801)
Recruiting
- Advanced Solid Tumors
- Drug: SYHA1801
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital
Jun 4, 2020
LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES Trial in Worldwide (chemo)
Recruiting
- LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES
-
Graz, Austria
- +86 more
Oct 17, 2019
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide
Active, not recruiting
- Localized Resectable Neuroblastoma
- +5 more
- Aldesleukin
- +6 more
-
Birmingham, Alabama
- +196 more
Dec 30, 2022
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Using Blood or Bone Marrow From Neuroblastoma or Noncancerous
Completed
- Localized Resectable Neuroblastoma
- +4 more
- Laboratory Biomarker Analysis
-
Jackson, Mississippi
- +1 more
Aug 3, 2018
Neuroblastoma
Completed
- Neuroblastoma
- Cytology Specimen Collection Procedure
- +2 more
-
Birmingham, Alabama
- +152 more
Jan 4, 2019